Sharps Compliance Stock Rating Upgraded by Zacks (SMED)
Sharps Compliance (NASDAQ:SMED) was upgraded by Zacks from a “neutral” rating to an “outperform” rating in a report issued on Monday, Analyst Ratings Network.com reports. The firm currently has a $3.30 price target on the stock. Zacks‘ target price would indicate a potential upside of 9.27% from the stock’s previous close.
Sharps Compliance (NASDAQ:SMED) traded down 3.71% on Monday, hitting $2.908. The stock had a trading volume of 75,778 shares. Sharps Compliance has a one year low of $2.01 and a one year high of $3.64. The stock’s 50-day moving average is $2.76 and its 200-day moving average is $2.81. The company’s market cap is $44.6 million.
Sharps Compliance (NASDAQ:SMED) last issued its quarterly earnings data on Wednesday, August 14th. The company reported ($0.05) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.04) by $0.01. The company had revenue of $5.30 million for the quarter, compared to the consensus estimate of $5.18 million. During the same quarter in the prior year, the company posted ($0.04) earnings per share.
Sharps Compliance Corp. is a provider of solutions for management of medical waste and unused dispensed medications generated outside of the hospital and large health care facility setting, serving more than 4,000 customers in all 50 states.
To view Zacks’ full report, visit www.zacks.com
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.